January Dividend Kings And Princes: 3 Buys And 2 To Watch

06:01am, Saturday, 31'st Dec 2022 Seeking Alpha
Dogs of the Dow has published a 2022 list detailing the latest 41 Dividend Kings and 2 Princes. Here are 3 dividend stocks to Buy and 2 to Watch.
"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years." - Dogs of th

Is First Trust Capital Strength ETF (FTCS) a Strong ETF Right Now?

11:20am, Tuesday, 27'th Dec 2022 Zacks Investment Research
Smart Beta ETF report for FTCS
I went cold on Parker Hannifin in my last piece, calling the company overvalued and too much of a risk at the time in the market, despite recovering from dipping. In this article, I'm revisiting Parke

Parker-Hannifin Remains Highly Attractive

07:55am, Friday, 23'rd Dec 2022
PH has grown its dividend for 66 consecutive years. Despite exceptionally strong business headwinds this year, PH is on track to grow its earnings per share to a new all-time high this year.

Reliable Passive Income: an Analysis on Dividend Kings

12:33pm, Tuesday, 13'th Dec 2022 The Motley Fool
A Dividend King is any stock that has increased its dividend for 50+ cosecutive years, doubling that of a Dividend Aristocrat.

Here's Why You Should Give Zebra Technologies (ZBRA) a Miss Now

01:34pm, Monday, 12'th Dec 2022 Zacks Investment Research
Zebra Technologies (ZBRA) is plagued by supply-chain disruptions, foreign currency headwinds and a weak demand environment. The company's bearish outlook for the fourth quarter is concerning.

PH vs. NDSN: Which Stock Should Value Investors Buy Now?

04:40pm, Friday, 09'th Dec 2022 Zacks Investment Research
PH vs. NDSN: Which Stock Is the Better Value Option?
PH vs. NDSN: Which Stock Is the Better Value Option?

CVS Health: Acquisitions May Not Create True Value

08:19am, Thursday, 08'th Dec 2022 Seeking Alpha
CVS Health Corporation's last Q3 report underlines great revenue and free cash flow growth. Click here to read why my rating for CVS stock is a Buy.

Honeywell (HON), Nexceris Expand Partnership on EV Safety

05:31pm, Monday, 05'th Dec 2022 Zacks Investment Research
Amid growing demand for EVs, Honeywell (HON) and Nexceris team up to address safety concerns and develop sensor-based solutions to prevent thermal runaway in EV batteries.

General Electric's (GE) Board Approves Healthcare Unit Spin-Off

04:00pm, Thursday, 01'st Dec 2022 Zacks Investment Research
General Electric's (GE) board approves the separation of its healthcare unit into a separate public company. The spun-off entity is set to be renamed GE HealthCare Technologies Inc.

Stanley Black (SWK) Shares Plunge 57% YTD Amid Headwinds

03:57pm, Thursday, 01'st Dec 2022 Zacks Investment Research
Stanley Black (SWK) is grappling with weakness in the Tools & Outdoor segment, supply-chain challenges, raw material cost inflation and foreign exchange woes.
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

General Electric (GE) to Offer CT Motion Injector in U.S.

02:56pm, Tuesday, 29'th Nov 2022 Zacks Investment Research
General Electric's (GE) Healthcare unit collaborates with Ulrich Medical to offer a multi-dose syringeless injector under the brand name CT Motion.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE